Tween 20 and Conjugates Sample Clauses

Tween 20 and Conjugates. When it comes to stability, DHFR is stable in 50 mM sodium phosphate buffer, however, these conditions are not ideal for AuNPs. AuNP are stable in citrate buffer and salt-less solutions, and they will start to aggregate once placed in high salt containing buffer. To combat these non-ideal conditions, DHFR-AuNP conjugates were initially stored in 10 mM sodium phosphate buffer at 4°C. However, the activity of the conjugated DHFR would decrease rapidly. It was hypothesized that the reason this was happening was due to aggregation of the DHFR that were caused by empty regions of the AuNPs binding together. Previous studies have used Tween 20, thiol groups and other heterocyclic compounds to cap these empty regions.33-35 For the purpose of these studies Tween 20 was used because Tween 20 has been used as a surfactant with DHFR in previous studies.36,37 FG Loop Mutant-15 nm AuNP and Alpha Helix Mutant-15 nm AuNP conjugates were used to test the effect of 0.005% Tween 20. Activity assays with these conjugates were run to determine the turnovers over multiple days to determine conjugate stability, and it was determined that the conjugates were active in Tween 20 for approximately 10 days when stored at 4C. The activity of the covalently bound conjugates increases when the samples are stored in 0.005% Tween 20, which is indicative of stability (Table 3.2). The pipette tips used were all lo-bind; however, conjugates would stick to them. This problem would have consequences by altering the concentration, causing errors when determining concentration and activity. However, Tween 20 also solved this problem (Figure 3.3). Tween 20 prevented the loss of sample on lo-bind pipette tips, most likely due to the capping of empty spaces on the AuNPs with Tween 20 to prevent exposed AuNPs from attaching to pipette tips. Sample Type Day 1 Turnover (s-1) Without Tween 20 Day 1 Turnover (s-1) With Tween 20 Day 7 Turnover (s-1) With Tween 20 FG Loop Mutant- 15 nm AuNP 0.3 ± 0.2 0.83 ± 0.07 0.71± 0.08 Alpha Helix Mutant- 15 nm AuNP 0.2 ± 0.1 0.71 ± 0.08 0.72± 0.04 Table 3.2: Enzyme turnovers for the DHFR-15 nm AuNP conjugates day one and seven days after conjugate preparation. (n=3) Figure 3.3 Pipette tips after transfer of DHFR-15 nm AuNP without Tween 20 (left) and with Tween 20 (right). The pink stain on the pipette tips is indicative of the conjugates sticking to the lo-bind pipette tips that were used throughout the experiments. Part IV: DHFR-AuNP Conjugate Characterization
AutoNDA by SimpleDocs

Related to Tween 20 and Conjugates

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Unbundled Channelization (Multiplexing) 5.7.1 To the extent NewPhone is purchasing DS1 or DS3 or STS-1 Dedicated Transport pursuant to this Agreement, Unbundled Channelization (UC) provides the optional multiplexing capability that will allow a DS1 (1.544 Mbps) or DS3 (44.736 Mbps) or STS-1 (51.84 Mbps) Network Elements to be multiplexed or channelized at a BellSouth central office. Channelization can be accomplished through the use of a multiplexer or a digital cross-connect system at the discretion of BellSouth. Once UC has been installed, NewPhone may request channel activation on a channelized facility and BellSouth shall connect the requested facilities via COCIs. The COCI must be compatible with the lower capacity facility and ordered with the lower capacity facility. This service is available as defined in NECA 4.

  • Biological Samples If so specified in the Protocol, Institution and Principal Investigator may collect and provide to Sponsor or its designee Biological Samples (“Biological Samples”). 12.2.

  • Preceptor A per diem Registered Nurse 2 may serve as a preceptor after successfully completing a preceptor workshop or equivalent documented training and agreeing to and being appointed to be specifically responsible for planning, organizing, and evaluating the new skill development of one or more RNs as appropriate enrolled in a defined orientation program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the new or transferring employee. The per diem RN 2 preceptor is eligible to receive preceptor premium pay when actually engaged in preceptor role responsibilities with/on behalf of the orienting RN. A per diem RN 2 substituting for the original preceptor during a period of absence and who has been designated to carry out the preceptor's complete responsibility (including following and/or adjusting the plan to meet learning needs and providing oral and written evaluation input) will receive preceptor pay. A preceptor may be assigned to a student when it is determined by the Employer that the employee has completed the required preceptor training or has agreed to and been appointed a preceptor. The employee is specifically responsible for planning, organizing, and evaluating the new skill development of the student as appropriately enrolled in a defined program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the student.

  • Insulin Insulin will be treated as a prescription drug subject to a separate copay for each type prescribed.

  • Musculoskeletal Injury Prevention and Control (a) The Hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

  • Agreement Xxx 0000 Part 3 Provisions relating to Balmoral South Iron Ore Project and certain other matters Division 2 Main provisions s. 14

  • Apple and Android Devices The following terms apply when you use a mobile application obtained from either the Apple Store or Google Play (each an “App Distributor”) to access the Site:

  • RE-WEIGHING PRODUCT Deliveries are subject to re- weighing at the point of destination by the Authorized User. If shrinkage occurs which exceeds that normally allowable in the trade, the Authorized User shall have the option to require delivery of the difference in quantity or to reduce the payment accordingly. Such option shall be exercised in writing by the Authorized User.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!